ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • T Cell Repertoire Diversity in HCV-Associated Hepatocellular Carcinoma Patients Waitlisted for Liver Transplantation and Receiving Liver-Directed Therapy

    K. Nunez, T. Sandow, A. Cohen, P. Thevenot

  • T-Cell Exhaustion in EBV DNAemic Solid Organ Transplant Recipients

    S. Kothari, T. Ku, D. Kumar, A. Humar, V. H. Ferreira

  • T-Cell Responses in Solid Organ Transplant Recipients with SARS-CoV-2 Infection

    V. H. Ferreira, T. M. Marinelli, T. Ku, M. Ierullo, B. Majchrzak-Kita, I. Bahinskaya, N. Pinzon, A. Humar, D. Kumar

  • T-cell-Mediated Immunity to Sars-cov-2 Defines Covid-19 Risk and Severity in Transplanted and Non-Transplanted Individuals and Associates with Myeloid-Derived Suppressor Cells

    C. Ashokkumar1, V. Rohan2, A. H. Kroemer3, S. Rao4, G. Mazariegos5, B. W. Higgs5, S. Nadig2, M. Ningappa5, T. Fishbein3, S. Subramaniam6, R. Sindhi7

  • Tacrolimus Dose Requirements in Lung Transplant Recipients on Systemic Azole Antifungals: The Influence of Race and Transplant Indication

    K. S. Walter1, T. Wert1, R. Coakley2, L. J. Lobo2, R. A. Evans1

  • Tacrolimus Shortage and the Rush to Convert: An Unexpected Burden on the System During the Covid-19 Pandemic?

    N. Pilch, L. Johnson, M. Aldoughaim, N. Patel, F. Bartlett

  • Tacrolimus Therapeutic Exposure is Not Consistently Predicted by Target Troughs or CYP3A5 Variants in Stable Renal Transplant Recipients

    K. Tornatore1, K. Attwood2, D. Brazeau3, B. Murray4

  • Tacrolimus Variability Score Outperforms Coefficient of Variation in Predicting Clinical Outcomes of Living Kidney Transplantation

    S. Yin, T. Song, Q. Zhong, T. Lin

  • Targeting Calcineurin/nfatc2 Signaling to Restore Pancreatic Beta-cell Function in Islet Transplantation

    C. Darden1, J. Mattke1, S. Vasu1, K. Kumano1, Y. Liu1, B. Naziruddin2, M. C. Lawrence1

  • Targeting Il-21 Receptor Shifts Tfh/tfr Balance and Ameliorateschronic Antibody Mediated Rejection

    Y. Nian, Z. Xiong, J. Zhao, Y. Fu

  • Taurodeoxycholic Acid and L-valine Ameliorate Macrophage Driven Alloimmunity in Obese Transplant Recipients

    M. Quante1, J. Iske1, D. Perkins2, M. Alegre3, H. Zhou1, A. Elkhal1, S. G. Tullius1

  • Temporal Changes in Renal Function Predict Waitlist Death or Deterioration in Pediatric Liver Transplantation

    N. Thalji, L. Thalji, S. Ibrahim, T. Diwan, P. Kamath, J. Heimbach

  • Textbook Outcome: A Novel Metric in Lung Transplantation Outcomes

    A. M. Ganapathi1, B. A. Whitson1, N. A. Mokadam1, B. C. Keller2, A. Logan1, G. Brock1, K. Washburn1, A. D. Schenk1

  • The Absence of T Follicular Regulatory Cells Prolongs Germinal Center Reactivity in Transplantation

    E. S. Crichton, S. Zeng, I. Badell

  • The Assesment of Pre-transplant Donor-reactive IL-21 Producing T Cells as a Tool to Identify Patients at Risk for Acute Rejection

    A. Mendoza Rojas1, T. van Gelder2, R. de Kuiper1, D. Reijerkerk1, M. C. Clahsen-van Groningen3, D. A. Hesselink1, C. C. Baan1, N. M. van Besouw1

  • The Association Between Environmental Determinants and High KDRI Organ Offer Acceptance Ratios

    A. M. Placona, C. Martinez, M. Stuart

  • The Association of Pre-Kidney Transplant C-Peptide Level with Post Transplant Outcomes

    A. J. Vinson, K. Tennankore

  • The Australian and New Zealand Living Kidney Donor Profile Index

    G. L. Irish1, S. Chadban1, N. Boudville2, S. B. Campbell3, J. Kanellis4, P. A. Clayton1

  • The Benefits of Sharing Non-Directed Donors Nationally Through Paired Exchange

    J. Verbesey1, A. G. Thomas2, A. D. Waterman3, J. Vucci1, G. Vranic1, A. Gilbert1, S. Ghasemian1, M. Cooper1

  • The Calculated Panel of Incompatible Epitopes (cPIE) in the Service of Equitable Access to Transplantation

    J. Lamsatfi1, B. Bingfan Liu1, S. Parto2, A. Lewin3, K. Oualkacha1, F. Claas4, P. Keown5, R. Sapir-Pichhadze6

  • The Clinical Significance of Preformed Anti-HLA-DQ Donor-specific Antibodies on Allograft Outcomes in Kidney Transplantation

    S. Lee1, C. Yang2, B. Chung2

  • The Clinical Significance of Preformed C1q-binding Donor-specific HLA Antibodies in Kidney Transplantation

    S. Lee1, C. Yang2, B. Chung2

  • The Clinical Validation of a Dried Blood Spot Method for Simultaneous Tacrolimus and Creatinine Measurement

    M. I. Francke1, S. Bouarfa2, B. van Domburg2, D. van de Velde2, M. E. Hellemons3, O. C. Manintveld4, S. M. Last-Koopmans5, M. B. Mulder2, D. A. Hesselink1, B. C. de Winter2

  • The Co-Occurrence of Newly Developed HLA Donor Specific Antibody and Positive C3d/C4d Profiles Along with Immune Therapy Non-Compliance in Pediatric Heart Transplant Recipients is a High Risk Indicator for Patient Mortality

    A. Zhang, C. Nasman, J. Allen, Y. Sun, D. Thomas, R. Rodriguez, C. Tan, G. Boyle

  • The Combined Effects of Simultaneous Portal Vein Thrombosis and Renal Dysfunction in Liver Transplant Recipients

    M. Molinari1, C. F. Carillo2, D. Dongling1, D. Jorgensen1, S. Dharmayan1, C. Kaltenmeier1, H. Liu1, J. Behari1, V. Rachakonda1, S. Ganesh1, C. Hughes1, A. Tevar1, H. Al Harakeh1, B. Emmanuel1, A. Humar1, R. Bataller1

  • The Confluence of Race, Socioeconomic Deprivation, and Waitlist Mortality for Children Awaiting Liver Transplant

    S. Wadhwani1, J. Ge1, L. Gottlieb1, C. Lyles1, A. F. Beck2, J. Bucuvalas3, U. Kotagal2, J. C. Lai1

  • The Contribution of Disulfide-hmgb1 Released During Ischemia-reperfusion Injury to Pro-inflammatory Macrophage Polarization Following Liver Transplantation

    A. Q. Terry, R. A. Sosa, M. Rossetti, J. Nevarez-Mejia, B. V. Naini, F. Kaldas, V. Groysberg, S. Younan, R. Busuttil, D. W. Gjertson, J. W. Kupiec-Weglinski, E. Reed

  • The Development and Characterization of AT1501, an Anti CD40L Antibody Lacking Fc Effector Function

    S. Perrin1, A. Gill2, C. Gill2, F. Vieira2, K. Thompson2, J. Lincecum2, B. Jiang2

  • The Differential Impact of Size Mismatch in Live versus Deceased Donor Kidney Transplant

    A. J. Vinson1, T. Skinner2, B. Kiberd3, D. Clark1, K. Tennankore1

  • The Edge of Glory: Determinants of Success and Failure for Prolonged Cold Ischemia in Kidney Transplantation

    A. Turner1, M. Hamidi1, V. Ariyamuthu2, R. Harland1, B. Tanriover2

  • The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Meld and Exception Statuses

    A. Wey1, S. Noreen2, S. Gentry3, N. Salkowski1, M. Cafarella2, R. Hirose4, J. Trotter5, D. Segev6, A. Israni1, J. Snyder1, B. Kasiske1

  • The Effect of Covid-19 on Offer Acceptance Rates by Age and Race Groups

    A. Wey1, J. Miller1, Y. Ahn1, D. Musgrove1, A. Hart1, N. Salkowski1, M. Skeans1, R. Hirose2, A. Israni1, J. Snyder1, B. Kasiske1

  • The Effect of Daratumumab (Dara, Humanized Anti-CD38 Monoclonal Antibody) on Immune Cells In Vitro and in a HLA-Sensitized Kidney Transplant Patient (HS KTx Pt) Desensitized (DES) with Dara

    S. Ge1, M. Chu1, A. De Guzman1, E. Ortiz1, A. Vo2, N. Ammerman2, S. C. Jordan2, M. Toyoda1

  • The Effect of Delayed Graft Function on Early versus Late Mortality Following Kidney Transplantation

    W. Irish1, Y. Fu2, D. B. Leeser1, K. V. Ravindra3, C. Haisch1, J. Tuttle1

  • The Effect of the Affordable Care Act on Insurance Status, Waitlist, and Transplant Outcomes in Liver Transplantation

    B. I. Shaw1, M. L. Samoylova1, V. Wang2, T. Risoli Jr3, S. Peskoe3, K. Caddell3, L. M. McElroy1

  • The Effect of the Different Donor-Derived HLA T-Cell Epitope Targets on the Development of T Cell-Mediated Rejection After Kidney Transplantation

    A. Senev, E. Van Loon, M. Emonds, M. Naesens

  • The Efficacy of Delayed Fc-nonbinding Anti-CD3 Antibody Treatment in Sensitized Allogeneic Mouse Heart Transplantation

    T. Ota1, R. Goto1, R. Kanazawa1, K. Shibuya1, Y. Ganchiku1, N. Kawamura2, M. Watanabe2, M. Fukai1, T. Shimamura3, A. Taketomi1

  • The Evaluation of Living-Related Kidney Transplantation Donors in Autosomal-Dominant Polycystic Kidney Disease

    T. Kikuchi1, K. Unagami2, Y. Kobari3, T. Yagisawa3, T. Kanzawa3, K. Omoto3, A. Uemura1, H. Ishida2, K. Tanabe3

  • The Evolution of the National Liver Review Board

    S. Noreen1, J. Trotter2, J. Pomposelli3, M. Cafarella1, J. Heimbach4

  • The Experience of 1000 Hand Assisted Laparoscopic Donor Nephrectomy for Living Donor Kidney Transplantation

    T. Hiramitsu1, T. Tomosugi2, K. Futamura2, M. Okada2, N. Goto2, T. Ichimori2, S. Narumi2, Y. Watarai2

  • The Extremes of KDPI: Even KDPI 95%+ Kidneys Can Be Used Successfully

    A. Gilbert, J. Verbesey, B. Thomas, J. Moore, M. Cooper

  • The Gut Microbiome in Heart Transplantation: A Prospective Pilot Study

    M. Dela Cruz1, E. Littmann2, R. Nayak2, C. Lehmann2, R. Keskey3, T. Baker3, H. Lin2, A. Bennett1, G. Kim1, S. Pinney1, E. Pamer2, A. B. Nguyen1

  • The Gut Microbiota Diversity and Metabolite Production is Reduced in Liver Transplant Recipients and Associated with Post-Operative Infection

    C. J. Lehmann, R. Keskey, R. Nayak, E. Littmann, E. Pamer, T. Baker

  • The Gut Microbiotainduces Local and Systemic Immune Modulation

    V. Saxena, R. Lakhan, J. Iyyathurai, W. Piao, L. Li, T. Zhang, M. W. Shirkey, B. Ma, E. F. Mongodin, J. Bromberg

  • The Harmful Effect of Retained Peripheral Cells During Flushing and Static Cold Storage in Rat Liver Normothermic Machine Perfusion

    O. Haque1, C. A. Pendexter2, J. F. Markmann2, K. Uygun2, H. Yeh2, S. N. Tessier2

  • The Hepatoprotective Role of Innate Lymphoid Cells in Liver Transplantation

    H. Kojima, H. Hirao, H. Zhang, K. Kadono, K. J. Dery, Y. Zhai, J. Kupiec-Weglinski

  • The Impact of 4-weeks of Supervised Exercise on Frailty and Lower Extremity (LE) Function in Patients with Advanced Chronic Kidney Disease (CKD)

    E. Lorenz, L. Hickson, R. Weatherly, K. Thompson, M. Hogan, C. Kennedy

  • The Impact of Combined Warm and Cold Ischemia Times on Post Transplant Outcomes

    M. E. Foley1, A. J. Vinson2, K. K. Tennankore2

  • The Impact of Covid-19 in Kidney Transplant Recipients: A Systematic Review and Meta-analysis

    J. Kumar1, J. Pyda2, I. Reccia3, F. VIrdis4, P. Bachul1, R. Barth1, Y. Becker1, J. Fung1, P. Witkowski1

  • The Impact of Covid-19 Pandemic on Living Donor Liver and Renal Transplantations in Japan: A Nationwide Survey

    S. Yamanaga1, T. Hibi2, R. Osawa3, K. Yuzawa4, H. Egawa5, K. Kuramitsu6

  • The Impact of De Novo Dose-Adjustment Strategies with Tacrolimus XR (LCP-Tac) in Kidney Transplant Recipients

    T. Carcella, F. Bartlett, N. Patel, V. Rohan, D. Taber

  • The Impact of Diabetes on Young Transplant Recipients: An American Perspective

    J. M. Loera, S. C. Barrett, T. S. Zhang, A. A. Awan, B. V. Murthy, R. T. Cotton, C. A. O'Mahany, N. T. Galvan, J. A. Goss, A. A. Rana

  • The Impact of Donor Age and Donor-Recipient Age Difference on Living Donor Kidney Transplantation

    T. Hiramitsu1, T. Tomosugi2, K. Futamura2, M. Okada2, N. Goto2, T. Ichimori2, S. Narumi2, Y. Watarai2

  • The Impact of Donor and Recipient Age Differenceon Long Term Prognosis in Young Liver Transplant Recipients

    A. Pita, A. Moro, J. C. McVey, D. J. Firl, M. Fujiki, T. Diago, C. Quintini, F. Aucejo, C. D. Kwon, K. V. Menon, K. Hashimoto, B. Eghtesad, C. Miller, K. Sasaki

  • The Impact of Early Narcotic Administration on Intestinal Transplantation Survival at an Urban Medical Center

    L. Maliekal1, N. Beltran2, Y. Muszkat2, S. Nagai2, S. Jafri2

  • The Impact of Fixed-Dose Alemtuzumab in Renal Transplant Recipients According to Weight

    S. Mandala1, N. Khodieva2, A. Bigness1, S. Mohamed2, H. Mohammed1, K. Robichaux2, A. Brueckner3, R. Baliga4, J. Buggs5, A. Kumar1, L. Bowman3

  • The Impact of Health Literacy on Kidney Transplant Listing

    G. Chen1, J. Siahaan2, L. Leon Novelo2, I. Rizvi3, A. M. De Golovine4, A. R. Edwards4, A. Pai4, W. A. Dar3

  • The Impact of High Kdpi on 1-year Post-transplant Graft Function and Survival in a Brazilian Cohort

    H. Tedesco Silva Junior, R. Demarchi Foresto, M. Hazin, B. Cassão, A. Aquino, J. Taddeo, C. Rosso Felipe, L. Requião Moura, J. Medina

  • The Impact of Lack of Access to Simultaneous Kidney and Pancreas Transplantation Due to Insurance Ineligibility – A Single Center Analysis

    Y. A. Qazi, E. Villalon, D. Samson, W. Mon, M. Smogorzewski

  • The Impact of Living Donors Aged 70 and Older on Living Donor Kidney Transplantation

    T. Hiramitsu, T. Tomosugi, K. Futamura, M. Okada, N. Goto, T. Ichimori, S. Narumi, Y. Watarai

  • The Impact of Maintenance Immunosuppression Withdrawal on Sensitization Status After Renal Graft Failure

    R. Hod Dvorai, A. Almonte, C. Hubbell, M. Laftavi, R. Shahbazov, R. Saidi, O. Pankewycz, J. Leggat, M. Hanlon, B. Gallay

  • The Impact of Splenectomy on Living Donor Liver Transplantation Using Small Grafts

    M. Fujiki, E. Aleassa, C. Quintini, F. Aucejo, K. Sasaki, B. Eghtesad, T. Diago, D. Kwon, C. Miller, K. Hashimoto

  • The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients

    D. Xu1, K. Richards1, K. Zheng1, H. Patel2, F. Cardarelli2, J. A. Pena3, A. Aala2

  • The Impact of the Covid-19 Pandemic on Measures of Transplant Activity is Higher in Lower-Income Countries: A Multinational Survey Study

    S. Sandal1, B. Boyarsky2, P. Chiang2, A. Massie2, D. Segev2, M. Cantarovich1

  • The Impact of the Kidney Transplant Journey on Patient’s and Parent’s Identities and Self-Management

    J. C. Dunbar1, E. E. Bascom2, W. Pratt2, J. Snyder2, J. M. Smith3, A. H. Pollack3

  • The Impact of Thromboelastography on Decreasing Blood Product Usage in Liver Transplantation

    A. Mohamed1, T. Kitajima1, S. Angappan2, K. Delvecchio1, A. M. Elsabbagh1, S. Yeddula1, M. Shamaa1, K. Collins1, M. Rizzari1, A. Yoshida1, M. Abouljoud1, J. El-Bashir2, S. Nagai1

  • The Implementation of the New Unos Policy That Relegates C-peptide and Body Mass Index Criteria Has Resulted in Shifting Recipient Demographics

    R. Teo, A. Rechnitzer, N. A. Muhdi, J. Torabi, M. Ajaimy, L. Liriano-Ward, Y. Azzi, C. Pynadath, P. Loarte-Campos, A. Brooks, J. P. Rocca, M. Le, E. Akalin, J. A. Graham

  • The Implications of Donor-Recipient Size Mismatch in Renal Transplantation

    I. D. Kostakis, N. Karydis, T. Kassimatis, N. Kessaris, I. Loukopoulos

  • The Importance of Persistent and Recurrent T Cell Mediated Rejection in Tacrolimus Treated Renal Transplant Recipients

    C. Rampersad1, I. W. Gibson2, D. N. Rush1, D. Pochinco3, P. E. Birk4, A. Goldberg4, T. Blydt-Hansen5, M. Karpinski1, J. Shaw1, J. Ho1, P. W. Nickerson1, C. Wiebe1

  • The Incremental Cost of Transplanting Patients with 100% cPRA Under the Kidney Allocation System: A Single Center Analysis

    R. Gumber, E. Kraus, K. Jackson, N. Alachkar

  • The Inflammatory Response in the Context of Tissue Injury: Roles of Tyro3, Axl, and Mer (TAM) Receptor Tyrosine Kinases in Liver Ischemia/reperfusion Injury

    J. Zhang1, H. Zhang1, M. Ni2, R. Busuttil1, J. Kupiec-Weglinski1, Y. Zhai1

  • The Initial Impact of Covid-19 on Reported Graft Failure Rates and Potential Confounding of Srtr Psrs

    A. Wey1, J. Miller1, D. Musgrove1, Y. Ahn1, M. Valapour2, N. Salkowski1, M. Skeans1, A. Massie3, R. Hirose4, D. Segev3, A. Israni1, J. Snyder1, B. Kasiske1

  • The Intersection of Cost, Quality, and Volume in Liver Transplant

    D. Axelrod1, R. Balakrishnan1, A. Harris2, S. Hohmann2, J. Snyder3, B. Kasiske3, M. Schnitzler4, K. Lentine4

  • The Landscape of Non-Directed Living Liver Donation in the United States

    L. R. Herbst, L. Zeiser, A. Massie, K. Herrick Reynolds, E. King, A. Gurakar, D. L. Segev, J. Garonzik Wang, A. M. Cameron

  • The Learning Curve Associated with De Novo Tacrolimus XR Use in a Racially Diverse Kidney Transplant Population

    F. Bartlett, T. Carcella, N. Patel, V. Rohan, D. Taber

  • The Lived Experience of Older Adult Kidney Transplant Recipients: Reflections on Embodied Selfhood in Later Life

    L. Kimberly

  • The Metagenomic Landscape of Renal Transplant

    A. Johnson1, G. Karadkhele2, C. Larsen2

  • The Microenvironment of Belatacept-Resistant Rejection

    A. Johnson, J. Zhang, C. Larsen

  • The Pathology of Heart Allograft Biopsies: Discrepancies in Interpretation Between Conventional Histology and the Molecular Microscope Diagnostic (MMDx®) System

    P. Randhawa1, A. Seitz2, Y. Huang1, B. Feingold2

  • The Pediatric National Liver Review Board: What Happens to Waitlist Registrations with Denied Exception Forms?

    J. Foutz1, C. Martinez1, A. Henderson1, E. K. Hsu2, E. R. Perito3, J. Heimbach4

  • The Perfect Candidate? The Stanford Integrated Psychosocial Assessment for Transplant

    E. J. Henricksen1, K. Stott2, S. Ilango2, Y. Moayedi3, K. Waddell4, H. I. Luikart4, J. Twiggs4, R. Lee1, B. M. Zhang5, W. Hiesinger6, K. K. Khush4, J. J. Teuteberg4

  • The Predictive Factors of Survival in Re-listed Patients Who Received Initial Liver Transplants Using Donation After Circulatory Death Grafts

    Y. Fouda, A. Moro, J. Mcvey, D. Firl, M. Fujiki, D. Teresa, F. Aucejo, C. Quintini, C. H. Kwon, K. Hashimoto, B. Eghtesad, K. Narayanan Menon, C. Miller, K. Sasaki

  • The Quality Incentive Program (QIP) is Associated with Increased Waitlisting for Transplantation

    J. T. Adler1, L. Xiang1, J. S. Weissman1, J. R. Rodrigue2, R. E. Patzer3, S. S. Waikar4, T. C. Tsai1

  • The Rate of Hospitalization Among Patients with Cirrhosis is More Than Twice as High as Patients Over 85 Years

    N. R. Mazumder1, K. Guo2, L. Zhao3, A. Kho1, K. Walters4, T. S. Carey4, C. Loftus1, D. P. Ladner1

  • The Relationship Between Health Literacy and Adverse Outcomes After Kidney Transplantation

    E. Lorenz, T. Petterson, C. Schinstock, W. Sanchez, K. Yost

  • The Relevance of Naturally Occurring Non-HLA Antibody to Antibody Mediated Rejection in Patients without Anti-HLA Antibodies After Kidney Transplantation

    H. Ishida1, T. Shimizu2, K. Unagami3, H. Shirakawa1, K. Tanabe1

  • The Risk of Post-donation Kidney Function Impairment for Prospective Living Kidney Donors with Persistent Isolated Microscopic Hematuria

    J. v. Weijden1, M. van Londen1, I. M. Nolte2, M. H. De Borst1, S. P. Berger1

  • The Role of Donor-derived Cell-free DNA Testing in Detecting Subclinical Kidney Allograft Rejection

    M. Dasari1, J. Hendele2, L. Sibulesky2, N. Leca3

  • The Role of Donor-derived Cell-free DNA to Detect Subclinical Acute Rejection in Kidney Allograft

    S. Park1, K. Guo2, R. Heilman3, E. Poggio4, D. Taber5, C. Marsh6, S. Kurian7, S. Kleiboeker8, J. Weems9, J. Holman10, L. Zhao2, R. Sinha8, S. Brietigam2, C. Rebello2, M. Abecassis11, J. Friedewald1

  • The Role of Histone Acetylation/methylation Mediated Epigenetic Modifications in the Pathogenesis of Non-alcoholic Steatohepatitis-associated Liver Carcinogenesis

    P. K. Rajan1, U. Utibe-Abasi1, J. D. Sanabria1, M. Banerjee2, G. Smith1, M. S. Schade1, J. Sanabria1, K. Sodhi1, S. Pierre2, Z. Xie2, J. I. Shapiro2, J. Sanabria1

  • The Role of Notch2 in Antibody-mediated Alloimmune Response

    R. Benedetti Gassen1, N. Murakami2, T. J Borges1, A. Al Jurdi1, A. Alessandrini1, L. V Riella1

  • The Role of Pre-transplant Rectal Screening for Azole-resistant Candida Species in Liver Transplant Candidates

    K. K. Patel1, M. M. Azar2, A. Koff3, K. Belfield4, D. R. Peaper5, J. Topal2, M. Malinis2

  • The Role of the B2 Microglobulin Trend in Patients with Delayed Graft Function After Kidney Transplant

    A. Perez-Gutierrez, P. J. Bachul, B. Juengel, P. Witkowski, D. DiSabato, R. Barth, J. Fung, Y. Becker

  • The Seattle Heart Failure Model is a Predictor of Mortality After Kidney Transplant in Patients with End Stage Renal Disease and Heart Impairment

    A. Perez-Gutierrez1, P. J. Bachul2, D. N. Danz3, B. Juengel2, M. Josephson2, J. Fung2, P. Witkowski2, B. Chung4, Y. Becker2

  • The Summarized Assessment of Endothelin a Receptors Expression in Renal Transplant Compartments is Associated with Antibody Mediated Rejection

    M. Banasik1, K. Nowanska1, P. Donizy2, K. Koscielska-Kasprzak3, S. Zmonarski1, M. Kuriata-Kordek1, A. Tukiendorf4, A. Hałoń2, D. Janczak5, M. Krajewska1

  • The Surgical Experience and Treatment Options for Hepatic Cystic Disease

    M. Crowley1, K. Robichaux2, A. Kumar1, J. Buggs3, J. Sokolich4

  • The Survival Benefits of Using Marginal Allografts in Liver Transplantation

    T. H. Malik1, E. L. Godfrey1, A. Rana2

  • The Trifecta Study: Calibrating Circulating Donor-Derived Cell-Free DNA at the Time of Indication Biopsies Against the Molecular Phenotype of the Biopsy Reveals a Prominent Association with NK Cell Genes

    P. Halloran1, Z. Demko2, A. Prewett2, J. Reeve1, P. Billings2

  • The Tumor-suppressor Signaling of the α1-na/k-atpase- Cav-1-src Complex at the Caveola in Nash Related Hepatocellular Carcinoma

    U. S. Udoh1, J. D. Sanabria1, M. Banerjee1, P. K. Rajan1, M. Schade1, J. A. Sanabria1, A. Mallick1, G. Smith1, G. U. Udoh2, K. Sodhi1, S. Pierre2, Z. Xie2, J. Shapiro2, J. Sanabria1

  • The Unintended Financial Consequences of Acuity Circles for Liver Allocation – Two-fold Increase in Import Fees and Higher Organ Acquisition Cost Despite Unchanged Travel Patterns

    A. Wall, S. Asrani, G. McKenna, E. Martinez, R. Ruiz, H. Fernandez, J. Bayer, A. Gupta, N. Onaca, R. Goldstein, J. Trotter, G. Testa

  • The Use of Donor Derived Cell Free DNA in Children to Monitor Therapy of Kidney Rejection

    A. Al-Uzri, M. Wright, K. Clark, R. Jenkins

  • The Use of Hcv Nat+ Organs in Hcv Negative Recipients with On-site Specialty Pharmacy Services: A Win for the Patient, the Transplant Center, and Society?

    M. Person, N. Patel, W. Simerlein, H. Meadows, D. DuBay, D. Taber

  • The Use of Organs from Donors That Do Not Meet Eligibility Criteria in the United States

    L. Deroos, M. Lavieri, D. Hutton, W. Marrero, N. Parikh

  • The Utility of PET/ CT Testing in Cardiac Risk Stratification of Adult Liver Transplant Candidates

    M. A. Tincopa1, R. Weinberg1, S. Sengupta1, J. Slivnick2, J. Corbett1, C. Sonnenday1, R. Fontana1, P. Sharma1

  • Therapeutic Enoxaparin Dosing in Lung Transplant Recipients

    S. Finder, M. Morrison, K. B. Harrison, S. A. Heeney

  • Therapeutic Response of Late Clinical Cell Mediated Rejection is Modeled by Chronicity Changes

    I. Melgarejo1, V. Visnawathan2, A. Sharma1, P. Sood1, C. Puttarajappa1, C. Wu1, N. Shah1, M. Molinari1, S. Hariharan1, R. Mehta1

  • Thrombolytic Therapy During Ex-Vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury

    O. Haque1, S. Raigani2, I. Rosales2, C. Carroll2, T. M. Coe2, S. Baptista2, H. Yeh2, K. Uygun2, J. F. Markmann2

  • Thrombotic and Hemorrhagic Complications Associated with Postoperative Anticoagulation After Pediatric Liver Transplantation

    C. Lemoine, K. Brandt, R. Superina

  • TIGIT Agonism Improves Immunosuppression of Cd8 T Cells by Ctla-4ig in a Treg Dependent Manner

    C. R. Hartigan, D. Liu, M. L. Ford

  • TIGIT Identifies Polyfunctional Donor-Specific CD4+ T Cells Lost After Kidney Transplantation

    A. C. van der List, N. H. Litjens, M. G. Betjes, M. Klepper

  • Time-averaged Oxygen Saturation During Donor Agonal Phase is Associated with Post-transplant Hepatic Graft Survival

    K. C. Eddinger1, E. M. Sonnenberg1, A. Kayastha2, N. Mahmud3, D. E. Schaubel2, P. L. Abt1

  • Tip60 Inhibitors Enhance Regulatory T Cells (Treg) Induction by Promoting Acetylation of Foxp3

    F. Fueyo-Gonzalez1, G. Vilanova2, M. Fribourg1

  • Tissue Specific Antigen-presentation in VCA Transplantation

    B. Kern1, J. Mengwasser1, A. Reutzel-Selke1, M. I. Ashraf1, D. Polenz1, K. Fuehrer1, S. Lippert1, P. Tang1, F. Martin1, C. Witzel1, I. M. Sauer1, J. Pratschke1, S. G. Tullius2

  • Tissue-Specific Features of Immunity Revealed by Single-cell RNA Sequencing of Healthy Human Kidney

    S. Q. Crome1, J. M. Szusz2, C. McEvoy1, J. An1, S. Clotet-Freixas1, S. A. MacParland1, G. D. Bader3, A. Konvalinka1

  • Titer Stability vs. Terminal Pre-transplant Titer: Titer History is Irrelevant for A2 to B Transplantation

    A. Gilbert1, S. Radomski2, J. Vucci1, B. Thomas1, M. Cooper1

  • To Whom do Pediatric Donor Organs Go?

    J. Smith1, M. Skeans2, R. Engen3, S. Bartosh4

  • Tolerability of De Novo and Conversion Belatacept Regimens in Kidney Transplantation

    T. Le1, J. Shoji2, J. Phillips1, D. Quan1

  • Tolerability of Mycophenolate Mofetil in Elderly Kidney Transplant Recipients: A Retrospective Cohort Study

    S. Witek1, G. Malat2, D. Sawinski2, C. Sammons2, C. LaFratte1, A. Forte1, R. Samudralwar1, S. Lyle1, J. Rashid1, J. Trofe-Clark2

  • TOLS are Novel Regulatory TLOs with A B Cell Signature

    I. Rosales1, Q. Yuan1, C. Yang1, P. Russell1, J. Madsen1, A. Alessandrini1, R. Colvin1, -. AA and RC2

  • Torque Teno Virus Load Predicts Allograft Rejection but Not Viral Infection After Kidney Transplantation; A Cohort Joint Modelling Study

    A. L. van Rijn1, H. F. Wunderink2, I. A. Sidorov1, C. S. de Brouwer1, A. C. Kroes1, H. Putter3, A. P. de Vries4, J. I. Rotmans4, M. C. Feltkamp1

  • Towards National Organ Sharing: Fair Distribution of Eplets in Canada

    S. Parto, B. Liu, W. Klement, S. Oikonomopoulos, I. Ragoussis, R. Sapir-Pichhadze

  • TPIAT Outcomes in Diabetic and Non-diabetic Patients

    M. A. Kanak, J. B. Spriggs, P. Coughenour, J. Kalivarathan, P. Saravanan, M. Levy

  • Transcriptomics and Proteomics Profiling of Complement Pathway (cp) Proteins in Biopsies With Polyomavirus Bk Nephropathy (bkvn)

    P. Randhawa1, F. Fei2, Y. Huang1, G. Tseng3, K. Xiao4

  • Transforming Growth Factor-Beta Induced Myeloid-Derived Suppressor Cells Promote Transplant Immune Tolerance

    F. Zhang

  • Transgenic Beta-cell Cxcl12 Expression and Stem Cell Mobilization Synergize to Suppress Type 1 Diabetes

    D. A. Alagpulinsa, A. Jajoo, M. H. Chapin II, M. C. Poznansky

  • Transgenic Overexpression of Human Ectonucleoside Triphosphate Diphosphohydrolase 1 (entpd1, Or Hcd39) in Pig to Primate Xenotransplantation Models

    R. Matheson1, K. Deng1, K. M. Lee1, Z. A. Habibabady1, C. G. Rickert1, K. J. Ahrens1, J. M. O1, D. Becerra1, P. Patel1, W. Westlin2, M. Youd2, N. Serifis1, T. M. Coe1, D. Cloonan1, A. M. Azimzadeh1, C. LeGuern1, J. C. Madsen1, S. C. Robson3, J. F. Markmann1

  • Transplant Center Provisional Yes Practices for Deceased Donor Kidneys

    A. M. Placona1, C. Martinez1, H. McGehee1, C. Van De Walker2, J. Rosendale1

  • Transplant Center Volume in High-risk Donors are Associated with Graft and Patient Survival

    M. A. Merzkani, H. Murad, M. Mattu, M. Wang, V. Hu, S. Chang, T. Alhamad

  • Transplant Center Volume in High-risk Recipient Association with Graft and Patient Survival

    M. A. Merzkani, H. Murad, M. Mattu, S. Husami, M. Wang, V. Hu, S. Chang, T. Alhamad

  • Transplant Data Platform – An Augmented Clinical Intelligence Framework

    C. Focht, W. Tian, J. Zeng, N. Dzebisashvili, S. Ghosh

  • Transplant Decision Making Concerns for Asian Patients with End-Stage Kidney Disease

    N. Singh1, A. Wasim1, G. Chawla1, F. Jamil1, M. Hamid1, R. Siddiqui1, E. Lui1, N. El-Dassouki1, M. Novak1, A. D. Waterman2, I. Mucsi1

  • Transplant Glomerulopathy in the Absence of Donor-specific HLA Antibodies: Risk Factors, Histopathological Features and Graft Outcome

    A. Senev, E. Van Loon, M. Emonds, M. Naesens

  • Transplant Trainee Education and Recruitment Experiences

    D. E. Cassidy1, A. E. Gomez-Rexode1, J. R. Santos-Parker1, M. S. Anderson2, L. M. McElroy3, M. E. Byrnes2, S. A. Waits2, V. S. Valbuena2

  • Transplant-free Survival in Alcohol-related Liver Disease (ALD) Patients Presenting with First Evidence of Ascites

    K. Fahoum1, N. T. Shen2, E. Basu1, J. Lee3, A. Kaplan2, A. Salajegheh4, R. Rosenblatt2, A. Jesudian2, C. Lucero2, B. Fortune2, M. M. Safford5, R. S. Brown2

  • Transplantation of Hepatitis C Positive Kidney and Pancreas Allografts Into Hepatitis C Naïve Recipients – A Single Center Experience as a Standard of Care

    K. Yadav1, A. Padiyar2, K. Zhao3, J. Rabets3, A. Jittirat2, S. Sclair4

  • Transplanting Hepatitis C Infected Organs Into Uninfected Recipients: A Pharmacy Perspective

    M. L. Holt, A. James, K. Gutierrez, T. Sparkman, J. Banbury, D. Jones

  • Treatment and Outcomes of Kidney Transplant Recipients with C4d Negative Antibody Mediated Rejection

    M. Walsh, L. Lineberger, M. Brokhof, N. Kenyon, N. Alvey

  • Treatment of Biopsy-Proven Pyelonephritis of the Transplanted Kidney is Associated with Better Graft Outcomes

    F. Aziz, C. Saddler, J. Alstott, K. Swanson, S. Parajuli, N. Garg, A. Djamali, D. Mandelbrot

  • Treatment of Bk Virus With Intravenous Immunoglobulin in Pediatric Kidney Transplant

    D. Mohammad, D. Kim, R. Baracco, G. Kapur, A. Jain

  • Treatment of Refractory Chronic Active Antibody-Mediated Rejection: Improvement in Histopathology are Delayed Compared to the Reduction in Donor Specific Antibodies

    K. R. Degner1, S. Parajuli1, F. Aziz1, N. Garg1, M. Mohamed1, D. A. Mandelbrot1, S. E. Panzer1, L. Hidalgo1, N. A. Wilson1, S. R. Reese1, K. Van Hyfte1, W. Zhong1, P. Nickerson2, A. Djamali1

  • Treg Engagement of Lymphotoxin Beta Receptor in Lymphatic Endothelial Cells is Required for Allograft Protection

    V. Saxena1, W. Piao1, L. Li1, Y. Xiong1, M. W. Shirkey1, J. Iyyathurai1, R. Lakhan1, R. Abdi2, J. Bromberg1

  • Treg Lymphotoxin Engages Lymphotoxin Receptor on Cancer and Endothelial Cells to Promote Cancer Metastatic Migration: Mechanisms for Treg-Cancer Interactions

    W. Piao, R. Oakes, C. Paluskievicz, J. Christopher, J. Bromberg

  • Trends and Outcomes Analysis of U.S. Transplant Centers Performing High Volumes of Hard to Place Kidneys

    D. Bahl1, A. Mahajan2, H. Aramada3, Y. Qazi3

  • Trends in Liver Donors for Liver Transplantation Over Twenty Years: Donor Changes in Gender, Relationships, and Education, but Racial Disparities Remain

    A. Kaplan, B. Fortune, R. Brown, MD, MPH, B. Samstein, K. Halazun, R. Rosenblatt

  • Trends in Living Donor Transplantation in USA

    N. Kemmer, C. Albers, S. Agrawal, R. Syed, M. Malespin, J. Buggs

  • Trends in Mortality Among Solid Organ Transplant Recipients Hospitalized for Covid-19 During the Course of the Pandemic

    M. R. Heldman, O. S. Kates, R. M. Rakita, E. D. Lease, C. E. Fisher, A. P. Limaye

  • Trends in the Recovery and Discard of Kidneys from Deceased Donors with Acute Kidney Injury from 2010-2018

    C. Liu1, S. Alasfar2, P. P. Reese3, S. Mohan4, M. D. Doshi5, I. E. Hall6, H. R. Thiessen-Philbrook2, Y. Jia2, D. E. Stewart7, C. Parikh2

  • Trends in Vascularized Composite Allograft (VCA) Waiting List and Transplant Activity in the U.S

    J. Wainright1, K. Swanner2, W. Cherikh1, D. Klassen3

  • Trends of Kidney Transplant Volume During Covid-19 Era

    G. Rajashekar1, S. Chang1, K. Lentine2, J. Wellen1, T. Alhamad1, M. Merzkani1, H. Murad1

  • Triple-Knockout Pig Red Blood Cells Are a Potential Alternative Source for Clinical Blood Transfusion

    T. Yamamoto1, M. H. Bikhet1, H. Q. Nguyen1, M. Javed1, D. Ayares2, H. Iwase1, H. Hara1, D. K. Cooper1

  • Tru and Sure -A Tale of Two Cities! Can Allosure Predict and Enhance Trugraf Results?

    Y. A. Qazi1, W. Mon1, S. Qazi2, C. Choi1, M. Smogorzewski1

  • True Living Donation Experiences: A Thematic Analysis of Storytelling from Kidney Living Donors

    E. Ho1, E. H. Wood2, R. Pines3, L. A. Davis4, S. M. Advani5, A. D. Waterman2

  • Trugraf Gene Expression Testing Can Discriminate Rejection in the Setting of Acute Kidney Injury

    N. Singh1, M. S. Naseer1, D. Aultman2, H. Shokouh-Amiri2, G. Zibari2

  • Tubastatin-a Mediated Protection from Liver Injury is Preserved in a Lymphocyte Deficient Model

    C. S. O'Brien1, P. Hernandez1, Z. Wang1, G. Ge1, A. Kozikowski2, W. Hancock1, M. H. Levine1

  • Twelve Live Births After Uterus Transplantation in the Dallas Uterus Transplant Study

    L. Johannesson, G. J. McKenna, A. Wall, J. Bayer, G. Testa

  • Two Hundred Total Pancreatectomy with Islet Autotransplantation Cases: A Single Center Experience

    K. Kumano1, S. Bruer1, G. Saracino1, M. Lawrence1, G. Testa1, A. Gupta1, N. Onaca1, E. Beecherl1, M. F. Levy2, B. Naziruddin1

  • Two Step Screening for Anxiety Symptoms in Solid Organ Transplant Recipients

    H. Lan, F. Jamil, N. Al Kaabi, R. Aser, K. Gyatso, H. Habbal, S. Macanovic, S. Dano, M. Novak, I. Mucsi

  • Two-for-One Kidney Transplant Outcomes

    C. Malanga1, H. Madeem2, K. Robichaux2, J. Buggs3, A. Kumar1, V. Bowers3

Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences